On Tuesday, Array Technologies ARRY earned a positive adjustment to its Relative Strength (RS) Rating, from 87 to 91. Please ...

Enliven Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 73 to 84.

Jason Fernando is a professional investor and writer who enjoys tackling and communicating complex business and financial problems. Somer G. Anderson is CPA, doctor of accounting, and an accounting ...

As of Tuesday, January 13, EUDA Health Holdings Limited’s EUDA share price has surged by 15.16%, which has investors ...

The U.S. stock market has been on a remarkable run, with major indexes hitting fresh record highs last week after the Fed delivered its first rate cut of the year. The 25-basis-point reduction, which ...

As of Tuesday, January 13, Navitas Semiconductor Corporation’s NVTS share price has dipped by 6.52%, which has investors ...

After a strong run last month, U.S. stocks have hit a patch of turbulence. Tariff headlines, including sweeping new levies on key partners and chip imports, spooked markets and pushed the S&P 500 to ...

Forbes contributors publish independent expert analyses and insights. John Navin is a Colorado-based journalist who writes about stocks. The S&P 500 on Friday hit another new high – it was brief as ...